Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Net Income towards Common Stockholders (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Net Income towards Common Stockholders for 8 consecutive years, with -$17.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Net Income towards Common Stockholders fell 41.06% to -$17.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$103.2 million, a 67.25% decrease, with the full-year FY2024 number at -$63.7 million, up 3.15% from a year prior.
  • Net Income towards Common Stockholders was -$17.7 million for Q3 2025 at Whitehawk Therapeutics, up from -$52.8 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$4.4 million in Q2 2021 to a low of -$87.1 million in Q3 2021.
  • A 5-year average of -$20.4 million and a median of -$16.0 million in 2021 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: crashed 1386.04% in 2021, then surged 83.38% in 2022.
  • Whitehawk Therapeutics' Net Income towards Common Stockholders stood at -$16.0 million in 2021, then grew by 12.99% to -$13.9 million in 2022, then fell by 16.93% to -$16.3 million in 2023, then decreased by 12.32% to -$18.3 million in 2024, then rose by 3.16% to -$17.7 million in 2025.
  • Per Business Quant, the three most recent readings for WHWK's Net Income towards Common Stockholders are -$17.7 million (Q3 2025), -$52.8 million (Q2 2025), and -$14.4 million (Q1 2025).